ES2326978T3 - Procedimiento de tratamiento del carcinoma hepatocelular. - Google Patents

Procedimiento de tratamiento del carcinoma hepatocelular. Download PDF

Info

Publication number
ES2326978T3
ES2326978T3 ES04777732T ES04777732T ES2326978T3 ES 2326978 T3 ES2326978 T3 ES 2326978T3 ES 04777732 T ES04777732 T ES 04777732T ES 04777732 T ES04777732 T ES 04777732T ES 2326978 T3 ES2326978 T3 ES 2326978T3
Authority
ES
Spain
Prior art keywords
baselineskip
zvegf3
sec
remains
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES04777732T
Other languages
English (en)
Spanish (es)
Inventor
Thomas E. Palmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of ES2326978T3 publication Critical patent/ES2326978T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/303—Liver or Pancreas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES04777732T 2003-07-25 2004-07-09 Procedimiento de tratamiento del carcinoma hepatocelular. Expired - Lifetime ES2326978T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49004703P 2003-07-25 2003-07-25
US490047P 2003-07-25

Publications (1)

Publication Number Publication Date
ES2326978T3 true ES2326978T3 (es) 2009-10-22

Family

ID=34115347

Family Applications (1)

Application Number Title Priority Date Filing Date
ES04777732T Expired - Lifetime ES2326978T3 (es) 2003-07-25 2004-07-09 Procedimiento de tratamiento del carcinoma hepatocelular.

Country Status (9)

Country Link
US (4) US20050191304A1 (enExample)
EP (1) EP1660135B1 (enExample)
JP (1) JP4709145B2 (enExample)
AT (1) ATE432716T1 (enExample)
CA (1) CA2529798C (enExample)
DE (1) DE602004021395D1 (enExample)
DK (1) DK1660135T3 (enExample)
ES (1) ES2326978T3 (enExample)
WO (1) WO2005011742A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6893637B1 (en) * 1999-10-21 2005-05-17 Zymogenetics, Inc. Method of treating fibrosis
US9884910B2 (en) * 2012-04-24 2018-02-06 Thrombogenics Nv Anti-PDGF-C antibodies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432673B1 (en) * 1998-12-07 2002-08-13 Zymogenetics, Inc. Growth factor homolog ZVEGF3
DK1137773T3 (da) * 1998-12-07 2008-12-08 Zymogenetics Inc Væsktfaktorhomolog ZVEGF3
US6893637B1 (en) * 1999-10-21 2005-05-17 Zymogenetics, Inc. Method of treating fibrosis

Also Published As

Publication number Publication date
JP2006528663A (ja) 2006-12-21
DK1660135T3 (da) 2009-09-07
US20090028865A1 (en) 2009-01-29
WO2005011742A1 (en) 2005-02-10
US20050191304A1 (en) 2005-09-01
US20110052588A1 (en) 2011-03-03
DE602004021395D1 (de) 2009-07-16
CA2529798C (en) 2014-09-16
CA2529798A1 (en) 2005-02-10
US20070054858A1 (en) 2007-03-08
ATE432716T1 (de) 2009-06-15
EP1660135A1 (en) 2006-05-31
EP1660135B1 (en) 2009-06-03
JP4709145B2 (ja) 2011-06-22

Similar Documents

Publication Publication Date Title
US7547437B2 (en) Method of treating fibrosis
ES2429034T3 (es) Uso de antagonistas de ANGPTL3 para el tratamiento de enfermedades hepáticas
ES2234818T3 (es) Procedimiento para tratar canceres que expresan el factor de crecimiento endotelial d.
ES2288321T3 (es) Fragmentos de factores de crecimiento de tejido conjuntivo, y metodos y usos de los mismos.
ES2434917T3 (es) Apoptosis provocada por el anticuerpo monoclonal anti-Her2
JP5132008B2 (ja) 血管内皮増殖因子２
JP5345997B2 (ja) 成長因子相同体ｚｖｅｇｆ３
JP2007297398A (ja) 突然変異上皮成長因子受容体を標的とする試薬および方法
US6352975B1 (en) Methods of treating hypertension and compositions for use therein
US8834879B2 (en) Methods of treating fibroproliferative disorders of the kidney or reducing kidney fibrosis
WO2000069454A9 (en) Suppression of endogenous igfbp-2 to inhibit cancer
ES2330918T3 (es) Inhibidor del activador del factor de crecimiento de hepatocitos para usar en la modulacion de la angiogenesis y la cardiovascularizacion.
ES2326978T3 (es) Procedimiento de tratamiento del carcinoma hepatocelular.
ES2272573T3 (es) Composiciones y metodos para mejorar la funcion renal.
US7727526B2 (en) Use of PTHrP antagonists for treating renal cell carcinoma
WO2001028586A1 (en) Method of treating fibrosis
ES2595388T3 (es) Método para el tratamiento de la glomerulonefritis